--- title: "BridgeBio’s Attruby challenges Pfizer’s Vyndamax legacy in pivotal ATTR trial" type: "News" locale: "en" url: "https://longbridge.com/en/news/286086171.md" description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser." datetime: "2026-05-12T10:39:45.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286086171.md) - [en](https://longbridge.com/en/news/286086171.md) - [zh-HK](https://longbridge.com/zh-HK/news/286086171.md) --- # BridgeBio’s Attruby challenges Pfizer’s Vyndamax legacy in pivotal ATTR trial A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser. ### Related Stocks - [PFE.US](https://longbridge.com/en/quote/PFE.US.md) - [BBIO.US](https://longbridge.com/en/quote/BBIO.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) ## Related News & Research - [Pfizer Inc. $PFE Stock Holdings Boosted by Canada Post Corp Registered Pension Plan](https://longbridge.com/en/news/286666435.md) - [European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors | PFE Stock News](https://longbridge.com/en/news/286244385.md) - [Pfizer Hemophilia Drug Win In Europe Adds Weight To Undervalued Thesis](https://longbridge.com/en/news/286344524.md) - [Pfizer’s New Japan RSV Vaccine Trial Signals Ongoing Expansion for PFE](https://longbridge.com/en/news/286445564.md) - [BridgeBio Pharma Touts Attruby Blockbuster Path, 3 Potential Pipeline Launches](https://longbridge.com/en/news/286199057.md)